Respiri Ltd RSH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.03
- Day Range
- A$0.03–0.03
- 52-Week Range
- A$0.02–0.05
- Bid/Ask
- A$0.03 / A$0.03
- Market Cap
- A$36.04 Mil
- Volume/Avg
- 1.2 Mil / 586,329
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 288.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 2
- Website
- https://respiri.co
Valuation
|
Metric
|
RSH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 10.23 |
Price/Sales | 288.14 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RSH
|
|---|---|
Quick Ratio | 0.52 |
Current Ratio | 1.62 |
Interest Coverage | — |
Quick Ratio
RSH
Profitability
|
Metric
|
RSH
|
|---|---|
Return on Assets (Normalized) | −146.75% |
Return on Equity (Normalized) | −284.15% |
Return on Invested Capital (Normalized) | −273.06% |
Return on Assets
RSH
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ksqkmcq | Sqsxhj | $184.2 Bil | |
SYK
| Stryker Corp | Wqldkmwhz | Xtkm | $125.1 Bil | |
MDT
| Medtronic PLC | Vjfypylg | Smvrs | $108.5 Bil | |
BSX
| Boston Scientific Corp | Hzwdxxmm | Snrbsc | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Tjqqvphbh | Pwlrqz | $51.4 Bil | |
DXCM
| DexCom Inc | Plvkkcqdx | Yprw | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Svznsnntwh | Brwtk | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Wvnhstyr | Fbrykt | $24.4 Bil | |
ALGN
| Align Technology Inc | Zxsxqwsn | Hblcnx | $21.7 Bil | |
PODD
| Insulet Corp | Lqccvgpbn | Cdwzh | $12.2 Bil |